Nam RK - Search Results

1

Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer.

Nam RK, Zhang WW, Trachtenberg J, Jewett MA, Emami M, Vesprini D, Chu W, Ho M, Sweet J, Evans A, Toi A, Pollak M, Narod SA. Nam RK, et al. Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1429-37. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14693733 Clinical Trial.

2

Detection of prostate cancer relapse with prostate specific antigen monitoring at levels of 0.001 to 0.1 microG./L.

Yu H, Diamandis EP, Wong PY, Nam R, Trachtenberg J. Yu H, et al. J Urol. 1997 Mar;157(3):913-8. J Urol. 1997. PMID: 9072598 Clinical Trial.

3

Prostate specific antigen velocity as a measure of the natural history of prostate cancer: defining a 'rapid riser' subset.

Nam RK, Klotz LH, Jewett MA, Danjoux C, Trachtenberg J. Nam RK, et al. Br J Urol. 1998 Jan;81(1):100-4. doi: 10.1046/j.1464-410x.1998.00523.x. Br J Urol. 1998. PMID: 9467484

4

Prostate cancer: 2. Natural history.

Nam RK, Jewett MA, Krahn MD. Nam RK, et al. CMAJ. 1998 Sep 22;159(6):685-91. CMAJ. 1998. PMID: 9780970 Free PMC article. Review. No abstract available.

5

Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis.

Nam RK, Fleshner N, Rakovitch E, Klotz L, Trachtenberg J, Choo R, Morton G, Danjoux C. Nam RK, et al. J Urol. 1999 May;161(5):1521-4. J Urol. 1999. PMID: 10210387

6

Comparison of molecular and conventional strategies for followup of superficial bladder cancer using decision analysis.

Nam RK, Redelmeier DA, Spiess PE, Sampson HA, Fradet Y, Jewett MA. Nam RK, et al. J Urol. 2000 Mar;163(3):752-7. J Urol. 2000. PMID: 10687970

7

Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen.

Nam RK, Diamandis EP, Toi A, Trachtenberg J, Magklara A, Scorilas A, Papnastasiou PA, Jewett MA, Narod SA. Nam RK, et al. J Clin Oncol. 2000 Mar;18(5):1036-42. doi: 10.1200/JCO.2000.18.5.1036. J Clin Oncol. 2000. PMID: 10694554

8

Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up.

Vassilikos EJ, Yu H, Trachtenberg J, Nam RK, Narod SA, Bromberg IL, Diamandis EP. Vassilikos EJ, et al. Among authors: nam rk. Clin Biochem. 2000 Mar;33(2):115-23. doi: 10.1016/s0009-9120(99)00099-5. Clin Biochem. 2000. PMID: 10751589

9

Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.

Nam RK, Elhaji Y, Krahn MD, Hakimi J, Ho M, Chu W, Sweet J, Trachtenberg J, Jewett MA, Narod SA. Nam RK, et al. J Urol. 2000 Aug;164(2):567-72. J Urol. 2000. PMID: 10893645

10

V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression.

Nam RK, Toi A, Vesprini D, Ho M, Chu W, Harvie S, Sweet J, Trachtenberg J, Jewett MA, Narod SA. Nam RK, et al. Urology. 2001 Jan;57(1):199-204. doi: 10.1016/s0090-4295(00)00928-6. Urology. 2001. PMID: 11164181

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters